- $3.51bn
- $3.63bn
- $1.36bn
- 80
- 45
- 60
- 65
2019 June 29th | 2020 June 27th | 2021 June 30th | 2022 June 25th | 2023 June 24th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,472 | 1,334 | 1,340 | 1,740 | 1,355 |
Cost of Revenue | |||||
Gross Profit | 497 | 544 | 611 | 943 | 716 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,479 | 1,265 | 1,193 | 1,397 | 1,201 |
Operating Profit | -6.3 | 68.9 | 147 | 342 | 154 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -20.8 | 159 | 120 | 321 | 126 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.1 | 121 | 88.7 | 256 | 73.6 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -22.9 | 119 | 79.6 | 258 | 73.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.9 | 119 | 79.6 | 258 | 73.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.282 | 2.15 | 1.57 | 6.74 | 1.83 |